Additionally, the improved splenic histology and upregulation of CD20 (a B-cell marker) suggest a supportive role of CML-CNP in B-cell activation and function (Pavlasova and Mraz, 2020). The gene discussed is CNP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.